Advertisement

Topics

Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed ...

22:06 EDT 22 Jun 2017 | BioMedReports - Blog

– Data to be presented during two oral sessions at the 2017 European Hematology Association (EHA) Annual Meeting –

Read more...

Original Article: Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed ...

NEXT ARTICLE

More From BioPortfolio on "Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...